Re-thinking the prostate cancer diagnostic pathway: the acceptability of the Rapid Access Prostate Imaging and Diagnosis (RAPID) pathway
BAUS ePoster online library. Bertoncelli Tanaka M. 06/25/19; 259472; P10-4 Disclosure(s): I have no actual or potential conflict ofinterest in relation to this program/presentation
Mariana Bertoncelli Tanaka
Mariana Bertoncelli Tanaka
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Rate & Comment (0)
Introduction and Objective
Our new 'one-stop' Rapid Access Prostate Imaging and Diagnosis (RAPID) pathway, across three hospitals in our region, streamlines the traditional pathway. We aimed to determine patient acceptability of the combination of same-day mpMRI, clinical review and transperineal prostate biopsy or discharge.

METHODS

Consecutive patients on the RAPID pathway were approached for detailed feedback via standardised questionnaires through an independent third party to minimize data collection bias. Patients were approached on only certain days.

Results
Of 837 patients within RAPID (April/2017 to September/2018), 62 completed the questionnaire. The mean time from referral to mpMRI +/- biopsy was 10.3 (7 to 13) days. 83% (52/62) thought that time from GP referral to first appointment was sooner than expected. 66% (41/62) of patients stated that time from referral to final diagnosis was shorter than expected. 12.9% (8/62) would have preferred the mpMRI and biopsy on different days. The overall patient's experience was rated as very good by 54/62 of patients, fairly good in 7/62 of cases and only one report as neutral experience. There was no negative experience reported. All patients stated that there was a good interaction between primary and specialist care whilst in the pathway.

Conclusions
The RAPID pathway provides a fast-access, robust, one-stop approach to prostate cancer diagnostics. Patient acceptability is high. As a result of our clinical and patient acceptability, further roll-out to 3-4 more centres is underway.
Introduction and Objective
Our new 'one-stop' Rapid Access Prostate Imaging and Diagnosis (RAPID) pathway, across three hospitals in our region, streamlines the traditional pathway. We aimed to determine patient acceptability of the combination of same-day mpMRI, clinical review and transperineal prostate biopsy or discharge.

METHODS

Consecutive patients on the RAPID pathway were approached for detailed feedback via standardised questionnaires through an independent third party to minimize data collection bias. Patients were approached on only certain days.

Results
Of 837 patients within RAPID (April/2017 to September/2018), 62 completed the questionnaire. The mean time from referral to mpMRI +/- biopsy was 10.3 (7 to 13) days. 83% (52/62) thought that time from GP referral to first appointment was sooner than expected. 66% (41/62) of patients stated that time from referral to final diagnosis was shorter than expected. 12.9% (8/62) would have preferred the mpMRI and biopsy on different days. The overall patient's experience was rated as very good by 54/62 of patients, fairly good in 7/62 of cases and only one report as neutral experience. There was no negative experience reported. All patients stated that there was a good interaction between primary and specialist care whilst in the pathway.

Conclusions
The RAPID pathway provides a fast-access, robust, one-stop approach to prostate cancer diagnostics. Patient acceptability is high. As a result of our clinical and patient acceptability, further roll-out to 3-4 more centres is underway.

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies